A Clinical study to Evaluate the Efficacy and Safety ofUnani Formulation (Itrifal Mulayyin) in the managementof Shaqiqa Muzmin (Chronic Migraine)
Phase 2
- Conditions
- Health Condition 1: G438- Other migraine
- Registration Number
- CTRI/2023/07/054994
- Lead Sponsor
- State Unani Medical College, Himmatganj Prayagraj
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Clinically diagnosed Patients with chronic migraine as per ICHD criteria
2.Patients aged between 18-60 years
3. Either gender
4. Willing to fill daily headache diary
5. Patient willing to sign written informed consent
Exclusion Criteria
1. Non-migrainous headache: tension-type headache; cluster headache; chronic
paroxysmal or non-paroxysmal hemicranias
2. Familial hemiplegic migraine
3. Below 18 and above 60 years
4. Pregnancy and Lactating women
5. Patients with Neuropsychiatric illness
6. Patients with significant co-morbidity
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Visual Analogue scale (VAS) <br/ ><br> 2. Migraine disability assessment (MIDAS) <br/ ><br>Timepoint: Baeseline ,0,15,35,45 days
- Secondary Outcome Measures
Name Time Method Itrifal Mulayyin is effective in chronic migraine <br/ ><br>Timepoint: 0 & 45 day